PARSIPPANY, N.J., Jan. 27, 2011 /PRNewswire/ — Significant
flooding occurred in many areas of Queensland during late December
2010 and early January 2011. Thousands of residents were
affected. A disaster relief appeal, the ‘Premier’s Disaster
Relief Appeal’, was launched on 29 December 2010, by Premier of
Queensland, Anna Bligh. DSM recognizes the efforts of
Queenslanders who pitched in to help their fellow citizens clean-up
in the wake of the floods and help families in need, many of whom
lost everything.
In May of 2010 DSM announced the signing of agreements to enter
a partnership with the Australian Governments (Queensland State
Government and the Commonwealth of Australia) to design, build and
operate the first major Australia-based mammalian biopharmaceutical
manufacturing facility, which will be located in Brisbane.
Currently under construction the facility will be located on
the Princess Alexandra Hospital Campus, 5.5 kilometers from the
center of Brisbane. Karen King, President of DSM Biologics
commented, “We are extremely concerned about the effects of the
severe flooding in Queensland and the need for support of those
impacted.”
Professor Peter Gray, Director of the Australian Institute of
Bioengineering & Nanotechnology which is based in Queensland,
visited DSM soon after the flooding. According to Professor
Gray, “The relief appeal will make a significant difference by
helping many in need as Queensland battles to recover from the
flooding. I am delighted to have DSM among our supporters.”
Alexander Wessels, President and CEO, DSM Pharmaceutical
Products, stated, “As a responsible corporate citizen around the
world, DSM is committed to the communities in which we work and
live. This is our humble gesture to aid those in need through the
auspices of the Premier’s appeal.”
For more information about supporting the Premier’s Disaster
Relief Appeal, visit
